Ability of IDO to attenuate liver injury in alpha-galactosylceramide-induced hepatitis model.
Ito H, Hoshi M, Ohtaki H, Taguchi A, Ando K, Ishikawa T, Osawa Y, Hara A, Moriwaki H, Saito K, et al. J Immunol. 2010 Oct 15; 185(8):4554-60. Epub 2010 Sep 15.